MARC E. GOLDBERG

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

ENANTA PHARMACEUTICALS INC

Filing Date Source Excerpt
2014-01-10 Consists of 554,467 shares beneficially owned by BioVentures Investors Limited Partnership II, for which Mr. Goldberg may be deemed to share voting and investment control.

Data sourced from SEC filings. Last updated: 2026-02-03